Nakul Raval, PhD

Nakul Raval's work is firmly rooted in the domain of PET science, where he focuses on the systematic development and evaluation of radioligands for brain imaging. His expertise spans both translational in vitro and in vivo assessments of these novel compounds. Deepening the scope of his research, Nakul holds a particular interest in the areas of substance use disorder and neurodegeneration. This interest manifests in his continued efforts towards the advancement of radioligands that address pathways associated with neurodegenerative conditions. With a methodical approach and a foundation in rigorous scientific principles, Nakul's contributions serve as valuable insights into the evolving landscape of neuroscience.